Infection, Wounds
Conditions
Keywords
surgical site healing treated with autologous platlet gel
Brief summary
This study will determine if autologous platelet gel (APG) on sternal incision and conduit sites will improve wound healing and decrease infection in coronary artery bypass grafting surgery patients.
Detailed description
The purpose of this study is to determine if the use of autologous platelet gel (APG) on sternal incision and conduit sites will improve wound healing and decrease the incidence of infection in patients undergoing coronary artery bypass grafting surgery
Interventions
BIOLOGICALautologous platelet gel
Patients will receive APG to the surgical site in the operating room. The control site will receive no treatment.
Sponsors
University of Nebraska
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
19 Years to 90 Years
Healthy volunteers
No
Inclusion criteria
* Any patient who meets criteria and consents to undergo a CABG procedure involving conduit sites and consents to this study.
Exclusion criteria
* Any patient, after inclusion, whom is later determined to have had on-going therapy that could influence wound healing such as radiation or chemotherapy, extensive steroid use, or accidental trauma such as burns, etc.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Healing and infection of surgical sites | 30 days | The surgical sites will be assessed for degree of healing and signs and symptoms of infection on post-op days one and three and during the patients' follow up visits in the clinic. |
Outcome results
None listed